Diazyme LP(A) Assay
Lipoprotein, Low-Density, Antigen, Antiserum, Control. 510(k) K082488, from General Atomics (Poway, CA). Product code DFC, class 2.
As of Nov 20, 2026, K082488 is an FDA 510(k) held by General Atomics, substantially equivalent on Jan 13, 2009 after 138 days, with no recalls tied to it in FDA's recall database.
- Review time: 138 days
- Recalls: 0
- Cited as a predicate by: 2 devices
- LP(A)-Latex Seiken Assay KitK013359 · Denka Seiken'S · Mar 8, 2002
- Diazyme Lipoprotein (A) Calibrator Set, Control SetK131556 · Diazyme Laboratories · Jun 26, 2013
- Cobas C Tina-Quant Lipoprotein (A) Gen 2 Assay Model 05852625190; Preciset LP (A) Gen 2 Califrator Set Model 05852641160K122722 · Roche Diagnostics · Nov 29, 2012
- Lipoprotein (a) Molarity AssayK253069 · Diazyme Laboratories, Inc. · Jun 16, 2026
- Tina-quant Lipoprotein(a) Gen.2 MolarityK241220 · Roche Diagnostics Operations · Jan 24, 2025
- Lp(a) UltraK211058 · SENTINEL CH. SpA · Dec 22, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 28, 2008
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5600
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files